Circulating immunoreactive interleukin-6 in cystic fibrosis.
about
Regulatory Crosstalk by Protein Kinases on CFTR Trafficking and Activity.Inflammatory related changes in bone mineral content in adults with cystic fibrosisAnti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosisInduction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae.Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis.Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.Candidate markers associated with the probability of future pulmonary exacerbations in cystic fibrosis patients.Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation.Inflammatory markers of lung disease in adult patients with cystic fibrosis.Iron and CF-related anemia: expanding clinical and biochemical relationships.Iron homeostasis during cystic fibrosis pulmonary exacerbationClinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbationsGrowth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction.Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational studySerum insulin-like growth factor-1 (IGF-1) during CF pulmonary exacerbation: trends and biomarker correlations.Pyocyanin effects on respiratory epithelium: relevance in Pseudomonas aeruginosa airway infections.Sputum biomarkers of inflammation in cystic fibrosis lung diseaseCirculating RNA transcripts identify therapeutic response in cystic fibrosis lung diseaseCFTR activity and mitochondrial function.Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients.Novel end points for clinical trials in young children with cystic fibrosisN-acetylcysteine and azithromycin affect the innate immune response in cystic fibrosis bronchial epithelial cells in vitro.Association of airway cathepsin B and S with inflammation in cystic fibrosis.Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line.Protein phosphatase 2A and protein kinase Calpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells.Elevated IgG4 serum levels in patients with cystic fibrosis.Expression of S100A12 (EN-RAGE) in cystic fibrosis.Predictors of mortality in adults with cystic fibrosis.Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening.Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis.Effects of fish oil treatment on bleomycin-induced pulmonary fibrosis in mice.The effect of infective exacerbations on sleep and neurobehavioral function in cystic fibrosis.Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Thromboelastogram as a Tool to Predict Hypercoagulability in Children With Cystic Fibrosis.Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis.Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis.Decreased right ventricular function in healthy pediatric cystic fibrosis patients versus non-cystic fibrosis patients.Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis
P2860
Q26770258-F189FB70-E66D-4977-BBF3-71A76DA6E41FQ33204318-C100D18E-B8F5-4491-9B6E-411DF4A9164AQ33985943-55078BDC-2487-445E-9FF3-C04A7262D13BQ34007570-49D97F1A-89AA-4AE2-BDBF-24E6ED4ACEC0Q34320262-C5305B6E-EE6A-47EF-ADCD-C1BE23CC9941Q35021504-9C63DFA1-CE7A-48CF-AF91-A96F135A35B0Q35095433-135C1C60-576E-4E9F-A8B2-59AFD209C378Q35506822-2247242A-8D02-4F84-A8F1-0FCA89379D61Q35565168-568D4D54-390E-410C-B6EE-C4D5F3C19B3AQ35749974-484F17E7-56E2-4595-9703-F4B3E1DAC2B3Q36144584-E49750EA-533B-4B1B-98ED-BD9EA88931B6Q36165392-6553A67B-E664-4C7A-A4BC-7658D4BCD4EAQ36274154-B00D4CF6-67A0-4986-A9D5-3BF94C9E08C2Q36338302-421BC79A-BA00-48EA-9933-79C0DC34CC97Q36345155-291954AF-A8A7-4323-B155-2BD453BFF098Q36452046-CA49F170-73CB-4A7F-A6C7-586E70F3C481Q36589251-54B8A715-F8B3-435C-A08F-4CD2BC227868Q36891552-B986792E-6ED1-426C-ADE5-688333B4B1E2Q36960790-AFC5FCC0-B388-4587-ABA8-913A276DC50EQ37133567-A46ABBAF-BDA3-4747-86E0-BF7AB0E50A03Q37702632-523FB178-342C-448F-9093-190589AF27A7Q38111791-884E8E48-8909-4AA0-91DC-20EA73195FA2Q38972117-766374C1-FC1E-4EA2-998F-A252021C83B2Q39856863-DC7FBC76-7551-4A74-837D-83A4A2AD0344Q40225402-494676BB-A6C6-4690-B30D-AFF9A8A9A13EQ40769002-D4FB5C56-1FDA-46ED-818F-DECBE194189DQ41702615-7A66BE81-19A7-4F32-AD8F-C80EC1DA7E07Q43059409-5153BE02-510A-4D71-8215-CE875A6BCF52Q44399979-0366166C-2851-4E68-9D8F-3C93BA9EA009Q44531237-66182363-34BD-459B-8AF3-158A4BA533C4Q45060297-75CD9FFE-44B0-49DB-9846-C6E497AA2C83Q46542708-23E0B077-9F84-4813-B75D-108B5A59B680Q47814064-6FBECFF1-F365-498F-A9DB-94DD8DEDA4CDQ47831284-C197E750-AF56-4116-BCA0-DBE27F31A6E7Q50984564-20D21305-BCE6-4593-B10D-AEB0DAD2FE28Q51678651-87712CF9-F465-44B8-ACB3-FA05068F4AC6Q51738556-838C3DDF-7175-450D-A991-10B04B77B912Q54545568-86D6C6F8-35C3-47EB-B508-5AF50B316095Q56638116-07322DB5-1C79-4EA2-8FBA-0136E3D49101
P2860
Circulating immunoreactive interleukin-6 in cystic fibrosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Circulating immunoreactive interleukin-6 in cystic fibrosis.
@en
Circulating immunoreactive interleukin-6 in cystic fibrosis.
@nl
type
label
Circulating immunoreactive interleukin-6 in cystic fibrosis.
@en
Circulating immunoreactive interleukin-6 in cystic fibrosis.
@nl
prefLabel
Circulating immunoreactive interleukin-6 in cystic fibrosis.
@en
Circulating immunoreactive interleukin-6 in cystic fibrosis.
@nl
P2093
P2860
P1476
Circulating immunoreactive interleukin-6 in cystic fibrosis.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.157.6.9704086
P407
P433
P577
1998-06-01T00:00:00Z